Does Intraoperative Cell Salvage Reduce Postoperative Infection Rates in Cardiac Surgery?

Autor: Edwin R. van den Heuvel, Jan van Klarenbosch, Adrianus J. de Vries, Willem van Oeveren

Publikováno v: Journal of cardiothoracic and vascular anesthesia, 34(6), 1457-1463. W B SAUNDERS CO-ELSEVIER INC
Journal of Cardiothoracic and Vascular Anesthesia, 34(6), 1457-1463. Elsevier

Objective: Primary outcome was the risk for infections after cell salvage in cardiac surgery. Design: Data of a randomized controlled trial on cell salvage and filter use (ISRCTN58333401). Setting: Six cardiac surgery centers in the Netherlands. Part

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::584870ee522b66a75fbb098501294ce7
https://doi.org/10.1053/j.jvca.2020.01.023

The short-term effects of RBC transfusions on intestinal injury in preterm infants

Autor: Willemien S. Kalteren, Arend F. Bos, Klasien A. Bergman, Willem van Oeveren, Jan B. F. Hulscher, Elisabeth M. W. Kooi

Publikováno v: Pediatric Research
Pediatric Research. Nature Publishing Group

Background Anemic preterm infants may require red blood cell (RBC) transfusions to maintain sufficient oxygen supply to vital organs. Transfusion treatment, however, may have adverse intestinal effects. We aimed to investigate the short-term effects

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce3e9a4877855fc82da2749630ade4d9
https://pubmed.ncbi.nlm.nih.gov/35115712

The optimal incubation time for in vitro hemocompatibility testing

Autor: Gerwin E. Engels, Sjoerd Leendert Johannes Blok, Willem van Oeveren

Publikováno v: Journal of Biomedical Materials Research. Part B: Applied Biomaterials, 107(7), 2335-2342. Wiley-Blackwell
Journal of Biomedical Materials Research. Part B, Applied Biomaterials

During hemocompatibility testing, activation products may reach plateau values which can result in less distinction between hemocompatible and hemo-incompatible materials. Of concern is an underestimation of the blood activation caused by the biomate

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a4c4db565be95203b3ecae2c6e2fa333
https://research.rug.nl/en/publications/7ea23481-0431-4217-83f5-a018021d11c3

Development of an in vitro system and model-based translational framework to assess haemolysis risk following intravenous abuse of medications containing polyethylene oxide

Autor: Eric Galia, Gerwin E. Engels, Peter Persich, Susanne Thun, Stéphan Benay, Willem van Oeveren

Publikováno v: Toxicology in Vitro. 65:104776

Multiple cases of potentially life-threatening thrombotic microangiopathy (TMA) have resulted from intravenous abuse of medications containing polyethylene oxide (PEO), most often Opana ER (oxymorphone hydrochloride extended release). No validated mo

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::330d0092b9a5ae09db7aabf04d8974f4
https://doi.org/10.1016/j.tiv.2020.104776

Short-term Effects of Tolvaptan in Individuals With Autosomal Dominant Polycystic Kidney Disease at Various Levels of Kidney Function

Autor: Peter Kappert, Holly B. Krasa, Dorothee Oberdhan, John Ouyang, Paul E. de Jong, Wendy E. Boertien, Frank S. Czerwiec, Remco J. Renken, Esther Meijer, Gert J. Ter Horst, Eric J. van der Jagt, Joachim Struck, Gerwin E. Engels, Ron T. Gansevoort, Willem van Oeveren

Publikováno v: American Journal of Kidney Diseases, 65(6), 833-841. W B SAUNDERS CO-ELSEVIER INC

Background: A recent study showed that tolvaptan, a vasopressin V-2 receptor antagonist, decreased total kidney volume (TKV) growth and estimated glomerular filtration rate (GFR) loss in autosomal dominant polycystic kidney disease (ADPKD) with creat

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::47f3c7fb09eac5da40cea3a9e9b15043
https://doi.org/10.1053/j.ajkd.2014.11.010